458 related articles for article (PubMed ID: 26444253)
21. Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement.
D'Angelo E; Ali RH; Espinosa I; Lee CH; Huntsman DG; Gilks B; Prat J
Am J Surg Pathol; 2013 Apr; 37(4):514-21. PubMed ID: 23211293
[TBL] [Abstract][Full Text] [Related]
22. The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma.
Li X; Anand M; Haimes JD; Manoj N; Berlin AM; Kudlow BA; Nucci MR; Ng TL; Stewart CJ; Lee CH
Histopathology; 2016 Oct; 69(4):551-9. PubMed ID: 26990025
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
24. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
Lee CH; Mariño-Enriquez A; Ou W; Zhu M; Ali RH; Chiang S; Amant F; Gilks CB; van de Rijn M; Oliva E; Debiec-Rychter M; Dal Cin P; Fletcher JA; Nucci MR
Am J Surg Pathol; 2012 May; 36(5):641-53. PubMed ID: 22456610
[TBL] [Abstract][Full Text] [Related]
25. Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma.
Micci F; Panagopoulos I; Bjerkehagen B; Heim S
Cancer Res; 2006 Jan; 66(1):107-12. PubMed ID: 16397222
[TBL] [Abstract][Full Text] [Related]
26. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors.
Jakate K; Azimi F; Ali RH; Lee CH; Clarke BA; Rasty G; Shaw PA; Melnyk N; Huntsman DG; Laframboise S; Rouzbahman M
Mod Pathol; 2013 Jan; 26(1):95-105. PubMed ID: 22918161
[TBL] [Abstract][Full Text] [Related]
27. Dysplastic lipoma: potential diagnostic pitfall of using MDM2 RNA in situ hybridization to distinguish between lipoma and atypical lipomatous tumor.
Hung YP; Michal M; Dubuc AM; Rosenberg AE; Nielsen GP
Hum Pathol; 2020 Jul; 101():53-57. PubMed ID: 32439322
[TBL] [Abstract][Full Text] [Related]
28. [Not Available].
Suster D; Ronen S; Peterson JF; Mackinnon AC; Hes O; Suster S; Lin DI
Hum Pathol; 2019 May; 87():28-36. PubMed ID: 30825458
[TBL] [Abstract][Full Text] [Related]
29. Low-grade Endometrial Stromal Sarcoma With Sex Cord-like Differentiation and PHF1-JAZF1 Fusion With Deletions: A Diagnostic Pitfall of JAZF1 FISH.
Ordulu Z; Avril S; Nardi V; Dias-Santagata D; Oliva E
Int J Gynecol Pathol; 2022 May; 41(3):244-250. PubMed ID: 34074959
[TBL] [Abstract][Full Text] [Related]
30. Colonic low-grade endometrial stromal sarcoma and orthotopic endometrial stromal tumor with limited infiltration sharing the JAZF1-SUZ12 gene fusion.
Tokinaga A; Furuya M; Niino H; Udaka N; Asai-Sato M; Sekido H; Miyagi E
Pathol Int; 2014 Apr; 64(4):178-82. PubMed ID: 24750188
[TBL] [Abstract][Full Text] [Related]
31. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
[TBL] [Abstract][Full Text] [Related]
32. Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases.
Kurihara S; Oda Y; Ohishi Y; Iwasa A; Takahira T; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1228-38. PubMed ID: 18580489
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
[TBL] [Abstract][Full Text] [Related]
34. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A; Multinu F; De Vitis LA; Cosio S; Carinelli S; Aletti GD
Gynecol Oncol; 2023 Apr; 171():95-105. PubMed ID: 36842409
[TBL] [Abstract][Full Text] [Related]
35. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
[TBL] [Abstract][Full Text] [Related]
36. Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma.
Weaver J; Goldblum JR; Turner S; Tubbs RR; Wang WL; Lazar AJ; Rubin BP
Mod Pathol; 2009 Jan; 22(1):66-70. PubMed ID: 18836421
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous and subcutaneous pleomorphic liposarcoma: a clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26.
Gardner JM; Dandekar M; Thomas D; Goldblum JR; Weiss SW; Billings SD; Lucas DR; McHugh JB; Patel RM
Am J Surg Pathol; 2012 Jul; 36(7):1047-51. PubMed ID: 22472959
[TBL] [Abstract][Full Text] [Related]
38. Genomic landscape of endometrial stromal sarcoma of uterus.
Choi YJ; Jung SH; Kim MS; Baek IP; Rhee JK; Lee SH; Hur SY; Kim TM; Chung YJ; Lee SH
Oncotarget; 2015 Oct; 6(32):33319-28. PubMed ID: 26429873
[TBL] [Abstract][Full Text] [Related]
39. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
[TBL] [Abstract][Full Text] [Related]
40. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]